Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.9 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |